[Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].

For the objective determination of its efficacy, Trental 400 was examined against placebo in a double blind trial in 40 patients with chronic peripheral circulatory disorders and concomitant symptoms of cerebro-vascular insufficiency typical of age. Treatment lasted 7 to 8 weeks with a dosage of 1 tablet 3 times a day. Trental 400 was significantly more effective than placebo in the treatment of peripheral and cerebral disorders. The preparation was well tolerated, subjectively and objectively.

RCT Entities:   Population Interventions Outcomes